d.achebe
TL2 · Leuven
Contributes reviews on supplier material. Based in Leuven.
Joined 19 June 2025 · last posted 4d
92 posts, newest first. Showing up to 150.
-
Why the Start Here categories exist, and what they are not for Replied, post #32 · Start Here › Welcome · 24 Jul 2026 · 20 likes A request rather than an answer: could whoever has the primary source for Start post it? I have seen the claim three times this month and each version had lost a…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #28 · Clinical › Bloodwork · 23 Jul 2026 · 13 likes Adding what did not work for me on egfr fluctuation, since the failures never get written up and they are half the useful information.
-
Retatrutide mass and identity: what a report should show Replied, post #21 · Compounds › Retatrutide · 19 Jul 2026 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Tracking intake honestly when appetite is absent Replied, post #101 · Nutrition & Training › Protein & intake · 16 Jul 2026 · 22 likes Everything in post #99 holds. The case it does not cover is the one I have. Temperature and texture change what is tolerable for a lot of people during the first weeks,…
-
Which categories are strict and which are relaxed, honestly Replied, post #12 · Start Here › Welcome · 13 Jul 2026 · 5 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #22 · Start Here › Welcome · 8 Jul 2026 · 6 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Electrolyte supplements: which ones do anything Replied, post #48 · Nutrition & Training › Hydration & electrolytes · 5 Jul 2026 · 11 likes Electrolyte supplements sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Journal club: STEP 3 and the intensive behavioural therapy floor Replied, post #11 · Evidence › Journal club · 30 Jun 2026 · 17 likes STEP 3 is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #10 · Practice › Side effects · 25 Jun 2026 · 5 likes The most useful thing anyone has posted about Taste changes and food aversion in this category was a table of what had been measured and by whom. That is what I would…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #53 · Analytics › HPLC & UHPLC · 20 Jun 2026 · 27 likes The arithmetic in post #50 is right; the assumption feeding it is the part to check. A relative retention time against a known peak travels much better than an absolute…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #78 · Practice › Administration · 13 Jun 2026 · 0 likes Post #76 put the caveat in the right place and I want to underline it. The arithmetic on Rotating between abdomen is the easy part and it is where the errors are, which…
-
[2026 update] What a good consultation looks like from the other side Replied, post #36 · Clinical › Prescriber conversations · 9 Jun 2026 · 3 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. Written quickly, so the reasoning may be tighter than…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #40 · Analytics › Impurities & related substances · 8 Jun 2026 · 30 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
[2026 update] Waist circumference technique and its repeatability Replied, post #15 · Outcomes › Progress reports · 7 Jun 2026 · 17 likes I had written a reply contradicting post #12 and deleted it. Here is what survived. Waist circumference technique is a good example of a question where the honest…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #38 · Practice › Storage & stability · 31 May 2026 · 0 likes Mean kinetic temperature is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #17 · Access › Insurance & coverage · 26 May 2026 · 14 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Naming conventions for research peptides and the confusion they cause Replied, post #5 · Compounds › Other compounds · 19 May 2026 · 4 likes This follows post #4 rather than contradicting it. One more thing on naming conventions for research peptides that took me far too long to see: the two figures people…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #8 · Documentation › Doc review · 17 May 2026 · 0 likes Answering the question post #6 raises rather than the one it answers. One caution on draft on reconstitution arithmetic: everything above assumes the underlying…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #116 · Compounds › Tirzepatide · 9 May 2026 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #95 · Devices › Syringes & needles · 7 May 2026 · 2 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #36 · Analytics › Impurities & related substances · 6 May 2026 · 17 likes Scavengers and cleavage-cocktail residues can persist and appear as small early-eluting peaks. They are process-related rather than sequence-related, which is a useful…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #21 · Safety › Contraindications · 27 Apr 2026 · 18 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. I would put the burden of proof on…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #15 · Sourcing › Independent verification · 25 Apr 2026 · 24 likes Post #13 put the caveat in the right place and I want to underline it. Independent measurement on a lot you bought yourself is the strongest evidence an individual can…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #2 · Practice › Reconstitution · 4 Apr 2026 · 26 likes Adding a reference point for Reconstituting a multi-strength kit. Mine is a single case, collected without controls, and I am posting the method alongside it so it can…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #42 · Research Methods › N-of-1 designs · 7 Mar 2026 · 16 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
-
Measurement error in a self-reported exposure Replied, post #114 · Evidence › Study critique · 27 Feb 2026 · 19 likes The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a smaller one than saying the result was chosen after the fact.
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #92 · Pharmacology › Pharmacokinetics · 25 Feb 2026 · 0 likes On post #90 — agreed on the reasoning, with one qualification. An observation about Half-life that I cannot explain and am posting anyway, on the principle that…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #81 · Meta › Site feedback · 24 Feb 2026 · 0 likes On topic list, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Five questions in one post gets you one answer — how to split them Replied, post #18 · Start Here › How to Ask · 23 Feb 2026 · 4 likes This follows post #15 rather than contradicting it. Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #47 · Pharmacology › Pharmacokinetics · 19 Feb 2026 · 0 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
-
Trifluoroacetate content and its consequences Replied, post #124 · Analytics › Impurities & related substances · 10 Feb 2026 · 1 like Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
[2026 update] What a purity-only report leaves out Replied, post #10 · Sourcing › Independent verification · 28 Jan 2026 · 13 likes I have no financial interest in anything named in this thread and I want to say so before I comment on purity-only, because it is the sort of subject where it matters.
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #18 · Start Here › Welcome · 27 Jan 2026 · 28 likes The compound pages are the fastest way to find out whether a question has a published answer at all. If the page says the trial is ongoing, that is the honest state of…
-
Coverage in the US: a map of the usual obstacles Replied, post #38 · Regional › North America · 18 Jan 2026 · 12 likes Marking my uncertainty on coverage explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises past…
-
Reporting a good result: why nobody bothers and why they should Started this topic · Sourcing › Vendor reports · 14 Jan 2026 · 19 likes Reporting a good result: why nobody bothers and why they should — setting out what I have, and where I think it stops being reliable. Reporting a good result: setting…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #80 · Sourcing › Independent verification · 14 Jan 2026 · 21 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
-
Heterogeneity as information rather than as a nuisance Replied, post #55 · Evidence › Meta-analyses · 9 Jan 2026 · 32 likes Post #53 describes the usual case. This is about the unusual one. Adding what did not work for me on heterogeneity, since the failures never get written up and they are…
-
Early satiety becoming a problem rather than a benefit Replied, post #23 · Practice › Side effects · 7 Jan 2026 · 4 likes Second this, and I would have said it less carefully.
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #22 · Compounds › Retatrutide · 10 Dec 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #33 · Compounds › Tirzepatide · 4 Dec 2025 · 26 likes Careful with the language on Tirzepatide in type 2 diabetes. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Documentation that appears only after payment Replied, post #88 · Sourcing › Red flags · 26 Nov 2025 · 12 likes Prices well below the rest of the market are a fact rather than a finding. They are worth noting and they do not establish anything on their own.
-
Temperature loggers worth the money — the long version Replied, post #80 · Devices › Cold chain · 24 Nov 2025 · 17 likes Narrowing post #77, because the general version has more than one answer. Suppliers that reship after a documented excursion without argument are doing something…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #105 · Practice › Reconstitution · 23 Nov 2025 · 0 likes I changed my mind about decimal-point error after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
-
Sleep quality changes during weight loss — what changed since Replied, post #48 · Wellbeing › Sleep · 2 Nov 2025 · 7 likes Sleep quality changes reported here have several plausible contributors, and separating drug effects from weight change, from schedule change, and from anxiety is…
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #17 · Analytics › Impurities & related substances · 28 Oct 2025 · 13 likes Post #14 describes the usual case. This is about the unusual one. Residual solvents: traces of solvents used in purification. These are usually tested by gas…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #16 · Compounds › Tirzepatide · 21 Oct 2025 · 25 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
Personal import allowances, compared — a second dataset Replied, post #11 · Access › International · 18 Oct 2025 · 16 likes Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page. I have left out…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #7 · Analytics › Method validation · 17 Oct 2025 · 0 likes Everything in post #3 holds. The case it does not cover is the one I have. The limit of quantitation determines what the impurity table can honestly contain. Peaks…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #83 · Practice › Storage & stability · 14 Oct 2025 · 15 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Happy to be the one who is wrong here…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #128 · Practice › Storage & stability · 1 Sep 2025 · 9 likes Door storage in a refrigerator is the warmest and most variable position in the appliance. A shelf at the back is a materially different environment. I am aware this is…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #66 · Clinical › Special populations · 23 Aug 2025 · 5 likes History of disordered eating is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #29 · Evidence › Preprints · 20 Aug 2025 · 1 like Understood. Thank you for being specific about the limits of it.
-
Coming back to: An 18-month record including the parts that went badly Replied, post #85 · Outcomes › Progress reports · 25 Jul 2025 · 0 likes The arithmetic in post #84 is right; the assumption feeding it is the part to check. Maintenance series are the ones this subcategory needs most and receives least. The…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #72 · Clinical › Comorbidities · 15 Jul 2025 · 3 likes This follows post #71 rather than contradicting it. A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake, and…
-
Thyroid function tests during substantial weight change Replied, post #4 · Clinical › Bloodwork · 11 Jul 2025 · 26 likes No notes. Posting so the count is not one.
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #59 · Compounds › Semaglutide · 7 Jul 2025 · 16 likes Post #57 is right about the mechanism and I think understates the practical bit. The number people quote for Semaglutide half-life is a central estimate presented…
-
Counter-ion content and its effect on measured mass Replied, post #76 · Analytics › Mass spectrometry · 27 Jun 2025 · 3 likes This follows post #74 rather than contradicting it. An acylated peptide has a mass that reflects the modification, so comparing against the mass of the unmodified…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #58 · Pharmacology › Pharmacokinetics · 21 Jun 2025 · 20 likes Clearance pathways sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #59 · Evidence › Journal club · 18 Jun 2025 · 31 likes Everything in post #55 holds. The case it does not cover is the one I have. Adding a null result on STEP 4. I looked, carefully, and found nothing, and null results…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #9 · Compounds › Oral incretins · 14 Jun 2025 · 0 likes Post #7 put the caveat in the right place and I want to underline it. The gastrointestinal tolerability profile of the oral formulation is broadly similar in character…
-
Sequence verification for an obscure compound: how it is done Replied, post #44 · Compounds › Other compounds · 25 May 2025 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Reverting an edit that had no revision note Replied, post #6 · Meta › Wiki maintenance · 24 May 2025 · 4 likes Support the scoping edit. A number in a maintained document gets quoted without its context roughly forever, so the context has to be inside the sentence rather than in…
-
Which panel is worth repeating and which is worth ignoring Replied, post #23 · Clinical › Bloodwork · 21 May 2025 · 0 likes Nothing in this subcategory is medical advice, and a panel with an unexpected result is precisely the situation where that matters. That is all I can say without…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #30 · Nutrition & Training › Protein & intake · 20 May 2025 · 4 likes Trying to state the Shakes versus food position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…
-
Lean mass preservation: what the evidence supports Replied, post #18 · Outcomes › Body composition · 16 May 2025 · 3 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Water content on a certificate and why it changes the arithmetic Replied, post #21 · Analytics › COA interpretation · 14 May 2025 · 0 likes Where I part company with post #19, and it is a narrow parting. I have three months of notes on water content and the honest summary is that the trend is real and the…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #111 · Evidence › Journal club · 22 Apr 2025 · 0 likes An honest declaration on STEP 1: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #89 · Devices › Cold chain · 21 Apr 2025 · 25 likes The documentation on Domestic fridge temperature mapping is better than this thread and I say that as someone who has posted in the thread.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #77 · Practice › Reconstitution · 12 Apr 2025 · 28 likes Everything in post #74 holds. The case it does not cover is the one I have. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5…
-
Reading an MS report that only gives you a single number Replied, post #47 · Analytics › Mass spectrometry · 7 Apr 2025 · 0 likes Resolution: "high resolution" commonly means Small point, but it is the one that usually catches people.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #68 · Documentation › Doc review · 21 Mar 2025 · 0 likes Building on post #65 rather than restating it. Something worth flagging about draft on reconstitution arithmetic: the strongest-sounding claims in this thread are the…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #67 · Sourcing › Vendor reports · 17 Mar 2025 · 2 likes Post #63 describes the usual case. This is about the unusual one. Recording a reorder result against the original is one of the highest-value contributions here,…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #30 · Analytics › Mass spectrometry · 9 Mar 2025 · 0 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
-
Distinguishing a deletion sequence by mass alone Replied, post #108 · Analytics › Mass spectrometry · 19 Feb 2025 · 21 likes Distinguishing a deletion sequence is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Scheduled maintenance and what will be unavailable Replied, post #46 · Meta › Announcements · 17 Feb 2025 · 10 likes Adding the measurement that post #44 says would settle it. Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #12 · Access › International · 25 Jan 2025 · 4 likes Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end.
-
Preparing for an appointment: one page, three questions Replied, post #5 · Clinical › Prescriber conversations · 20 Jan 2025 · 0 likes Picking up post #4: that is the part I would want checked first. Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #12 · Data & Tools › Calculators · 12 Jan 2025 · 0 likes Post #10 is the version of this I will quote in future. One addition. A titration planner is a scheduling aid rather than a clinical recommendation, and any tool that…
-
A promotion I argued against, and why I lost Replied, post #58 · Documentation › Doc review · 11 Jan 2025 · 2 likes Post #57 is right about the mechanism and I think understates the practical bit. Before the thread moves on from promotion — what is the sample size behind the claim? I…
-
Oxidation pathways for methionine and tryptophan Replied, post #35 · Analytics › Impurities & related substances · 28 Dec 2024 · 9 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Washout with a one-week half-life: the arithmetic Replied, post #52 · Research Methods › N-of-1 designs · 2 Dec 2024 · 1 like Reading back through, this was answered upthread and I missed it. My fault.
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #2 · Regional › UK & Ireland · 24 Nov 2024 · 8 likes On Pharmacy supply I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
-
Identical chromatograms across two different lots Replied, post #51 · Sourcing › Red flags · 19 Nov 2024 · 0 likes Adding a data point of agreement rather than a data point.
-
Reading a supplementary appendix and finding the interesting part Replied, post #19 · Evidence › Trials · 7 Nov 2024 · 1 like Reading a supplementary appendix has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Time to steady state after a dose increase Replied, post #25 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 15 likes Taking post #24 at face value and following it one step further. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #79 · Clinical › Prescriber conversations · 17 Oct 2024 · 5 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. The variance between people…
-
Signs of dehydration worth acting on Replied, post #30 · Safety › Adverse events · 16 Oct 2024 · 2 likes Summarising the signs of dehydration worth acting thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the…
-
Coming back to: Why the cheapest option is often not the cheapest Started this topic · Access › Pricing · 13 Oct 2024 · 14 likes Why the cheapest option is often not the cheapest — that is the question, and I have not found it answered plainly anywhere I have looked. Reading back through what has…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #24 · Clinical › Comorbidities · 7 Oct 2024 · 13 likes Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them. Adding it in case it saves somebody…
-
Coming back to: What consumer-accessible tests can and cannot determine Replied, post #7 · Analytics › Home & field testing · 19 Sep 2024 · 9 likes Adding a data point of agreement rather than a data point.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #62 · Sourcing › Independent verification · 16 Sep 2024 · 8 likes Answering the question post #60 raises rather than the one it answers. The record shows what was measured. Everything beyond that is inference and this site tries to…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #18 · Evidence › Preprints · 21 Jul 2024 · 0 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…